Skip to content
Clinical Trials – home

Comite Entreprise Paul Papin

Verifiedinfo

France Boulevard Jacques Monod, 44805 Angers, France

  • 134 trials recruiting
  • Non-small cell lung cancer · Breast cancer · Ovarian cancer
  • Adults and children

About Specializations

Comite Entreprise Paul Papin in Angers, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Breast cancer, Ovarian cancer, Neoplasm, and other specialisations. This site conducts important research.

Main research areas of the site

Medical Oncology – Non‑Small Cell Lung Cancer

The Comite Entreprise Paul Papin in Angers focuses on Neoplasms, specifically studying non‑small cell lung cancer (NSCLC) with both squamous and nonsquamous histology. Researchers are evaluating new treatment combinations to improve patient outcomes.

  • Overall survival comparison of novel therapy versus standard chemotherapy
  • Progression‑free survival assessment using blinded independent review
  • Evaluation of immunotherapy‑targeted agent synergy

With 76 investigators involved, the site’s patient‑centered approach aims to advance therapeutic options for advanced NSCLC after prior platinum‑based treatment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Boulevard Jacques Monod44805 AngersFrance
Recruiting now
134 trials
Conditions studied
137
Partner status
Verified

More sites in AngersFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

281 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:HLX43
  • Sponsor:Shanghai Henlius Biotech Inc.
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:BioNTech SE
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Medica Scientia Innovation Research S.L.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Seagen Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib Mesilate
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lenvatinib
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:BeOne Medicines I GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.